sanofi-aventis chief exec named chairman of PhRMA board
This article was originally published in SRA
Executive Summary
Christopher Viehbacher, the chief executive of sanofi-aventis, has taken over as chairman of the board of directors of US pharma industry association PhRMA. Mr Viehbacher replaces Jeffrey Kindler, who resigned as chairman and chief executive of Pfizer on 5 December.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents